Press Releases

05/10/08 DNA EpiCenter Announces Barbara McClintock, PhD, 2008 Class of DNA EpiCenter Scholars

05/06/08 Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs

04/22/08 Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institute’s 2nd Annual Challenge of Antibacterial Development Conference

04/14/08 Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council

04/03/08 Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference

01/04/08 Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741

04/25/07 Rib-X Pharmaceuticals and the Medical Research Council Announce Key Collaboration

06/20/06 Rib-X Pharmaceuticals Raises $50 Million in Series C Financing

06/01/06 Rib-X Pharmaceuticals and Wakunaga Pharmaceutical Company Announce License Agreement for Quinolone Antibiotic

12/19/05 Novel Antibiotic Discovery Firm Launches First Clinical Trial From Ribosome-Based Technology Platform

10/05/05 Rib-X Granted Key Antibiotic Drug Discovery Patents

07/16/04 C Boyd Clarke Joins Rib-X Pharmaceuticals' Board of Directors

01/08/04 World Renowned Ribosome Expert Dr Venkatraman Ramakrishnan Joins Rib-X Pharmaceuticals' Scientific Advisory Board

01/06/04 Dr George Milne Joins Rib-X Pharmaceuticals' Board of Directors

10/30/03 Rib-X Pharmaceuticals Receives US Patent for Technology Enabling Antibiotic Structure-Based Drug Design

05/01/03 Rib-X Pharmaceuticals Completes $63.5 Million Series B Financing

02/06/03 Rib-X Pharmaceuticals Names Graham Johnson PhD Vice President of Discovery

09/09/02 Rib-X Pharmaceuticals Opens New State-of-the-Art Facility

06/18/02 Robert A Conerly Named CFO of Rib-X Pharmaceuticals

01/02/02 Rib-X Pharmaceuticals Secures $22 Million in Series A Financing